Sign in

CIK 0001919246 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Pelthos Therapeutics Inc.

Sign in to watch
Ticker
PTHS
Exchange
NYSE
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
NV
Entity type
operating
EIN
863335449
Phone
919-908-2422
Business address
4020 STIRRUP CREEK DRIVE, SUITE 110, DURHAM, NC, 27703
Former names
Channel Therapeutics Corp, Chromocell Therapeutics Corp
  1. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
  2. 8-K Event Regulation FD disclosure
  3. 8-K/A Event Acquisition or sale completed · Results of operations
  4. 8-K Event Regulation FD disclosure
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. 8-K Event Material agreement · Acquisition or sale completed · New debt or obligation · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Other events
  7. 8-K Event Regulation FD disclosure
  8. 8-K Event Material agreement · Unregistered share sale · Auditor change · Shareholder vote results · Regulation FD disclosure · Other events
  9. 10-K Report Annual Report
  10. 8-K Event Material agreement · New debt or obligation
  11. 8-K Event Regulation FD disclosure
  12. 8-K Event Material agreement · New debt or obligation · Shareholder rights changed · Executive or director change · Bylaws or fiscal year change
  13. 8-K Event Shareholder vote results · Other events
  14. DEF 14A Proxy Proxy Statement
  15. 8-K Event Other events
  16. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
  17. 10-K Report Annual Report
  18. 8-K Event Other events
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Executive or director change · Other events

Page 2 of 3 · 42 filings